Faus & Moliner participates at the Seminar on Risk Sharing Agreements organized by CEFI

Since 2012, Spanish Law 29/2006 has included, as a criteria to consider when taking decissions on pricing and reimbursement of medicines, the so-called “return mechanisms” such as discounts or price reviews. On the other hand, it has been common, in recent times, to include mechanisms to reduce the uncertainty about the impact that the admission of new drug to reimbursement may have on public accounts.

In addition to these systems, market access of many new drugs in Spain is being managed in Spain through systems that include an assessment of expectations and/or of health outcomes. These systems, commonly known as risk sharing agreements or payment schemes based on results, have been analyzed in this Seminar, in which Jordi Faus has spoken about the main legal aspects to be considered.
In his presentation, Jordi Faus has explained the various types of risk sharing agreements that have been commonly used in Spain and has shared some of its experience in the negotiation and drafting of these agreements.